US Stock MarketDetailed Quotes

LGND Ligand Pharmaceuticals

Watchlist
  • 114.640
  • +0.695+0.61%
Close Dec 20 16:00 ET
  • 114.640
  • 0.0000.00%
Post 16:20 ET
2.17BMarket Cap46.04P/E (TTM)

Ligand Pharmaceuticals Key Stats

Ligand Pharmaceuticals Q3 2024 Earnings Date

Currency:USDNov 7, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
40.60M
51.81M
+11.21M
Beat Est.
+23.53%
+57.64%
+27.61%
EPS
0.61
-0.39
-1.00
Miss Est.
+182.89%
+33.90%
-163.59%
Strong Buy

Dec 22, 2024

Ligand Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 36.015M--
--2024/Q4-- / 39.026M--
Nov 7, 20242024/Q351.812M / 40.600M--
Aug 6, 20242024/Q241.531M / 34.264M--
May 7, 20242024/Q130.978M / 27.924M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 36.015M--
--2024/Q4-- / 39.026M--
Nov 7, 20242024/Q351.812M / 40.600M--
Aug 6, 20242024/Q241.531M / 34.264M--
May 7, 20242024/Q130.978M / 27.924M--

Unlock Free Earnings Estimates

Ligand Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 22, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data